Long-Term Assets: The sum of all assets classified as non-current.
Pharming Group N.V. Sponsored ADR (PHAR) had Long-Term Assets of $144.73M for the most recently reported fiscal quarter, ending 2023-09-30.
Income Statement Financials | |
$66.70M |
|
$3.50M |
|
$8.30M |
|
$58.40M |
|
$64.80M |
|
$1.90M |
|
$1.40M |
|
$3.30M |
|
$3.30M |
|
$3.50M |
|
$3.50M |
|
$3.50M |
|
$3.50M |
|
$1.90M |
|
$1.90M |
|
70.00M |
|
70.00M |
|
$0.05 |
|
$0.05 |
|
Balance Sheet Financials | |
$291.74M |
|
$9.65M |
|
Long-Term Assets |
$144.73M |
$436.47M |
|
$68.06M |
|
$129.73M |
|
$158.47M |
|
$226.53M |
|
$209.94M |
|
$140.09M |
|
$209.94M |
|
-- |
|
Cash Flow Statement Financials | |
$-28.88M |
|
$-125.48M |
|
$-0.02M |
|
$207.34M |
|
$54.65M |
|
$-152.69M |
|
$5.93M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.29 |
|
-- |
|
-- |
|
0.38 |
|
0.63 |
|
87.56% |
|
2.85% |
|
2.85% |
|
-- |
|
4.95% |
|
5.25% |
|
$-30.01M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.16 |
|
1.65 |
|
54.68 |
|
1.67% |
|
2.50% |
|
0.80% |
|
1.03% |
|
-- |
|
$-0.43 |
|
$-0.41 |